Home > Financial Ratios > BLISS GVS PHARMA

BLISS GVS PHARMA
Core EBITDA Growth

    Back to All Ratios
BLISS GVS PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BLISS GVS PHARMA
Please provide your vote to see the results

BLISS GVS PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Core EBITDA Growth(%) -9.8316.51-20.86-16.78-12.70

What is the latest Core EBITDA Growth ratio of BLISS GVS PHARMA ?

The latest Core EBITDA Growth ratio of BLISS GVS PHARMA is -9.83 based on Mar2023 Consolidated results.
Year Core EBITDA Growth
Mar2023-9.83
Mar202216.51
Mar2021-20.86
Mar2020-16.78
Mar2019-12.70

How is Core EBITDA Growth of BLISS GVS PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2023 -9.83
Negative
Mar2022 16.51
Positive
Mar2021 -20.86
Negative
Mar2020 -16.78
Negative
Mar2019 -12.7 -

Other Financial Ratios of BLISS GVS PHARMA


Compare Core EBITDA Growth ratio of peers of BLISS GVS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BLISS GVS PHARMA ₹1,295.1 Cr 7% 8.4% 63.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹360,452.0 Cr 1.1% -6.6% 56.7% Stock Analytics
CIPLA ₹113,132.0 Cr 0.2% -4.4% 54.3% Stock Analytics
DIVIS LABORATORIES ₹106,191.0 Cr 4.8% 18.9% 23.9% Stock Analytics
DR REDDYS LABORATORIES ₹103,512.0 Cr 4.3% 2.6% 29.9% Stock Analytics
ZYDUS LIFESCIENCES ₹95,954.5 Cr 2.2% -4.6% 86.6% Stock Analytics


BLISS GVS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BLISS GVS PHARMA

7%

8.4%

63.2%

SENSEX

1%

2.8%

23.9%


You may also like the below Video Courses